NCT02178917

Brief Summary

Spinal Cord Injury (SCI) affects a person's ability to move and feel sensation in the body. SCI is also an indirect cause of a persistent pain, called Central Neuropathic Pain (CNP). This pain typically develops several months after the injury. In 30-40% of SCI patients, severe CNP affects their everyday living including sleep and mood. Many patients give up work, not because of the injury, but because of pain. Medical treatment of CNP is moderately effective and costly, both to the patient and to the health care system. In previous research, characteristic 'signatures' of brain waves that are probably related to CNP have been defined. Based on this, a novel treatment for CNP based on neurofeedback was developed and clinically tested on five SCI patients. Electroencephalograph (EEG) was used to record patients' brain waves and these were shown to patients on a computer screen in a simple graphical form (e.g. bars). Patients were trained to change their brain activity at will and, as a consequence, their pain was reduced. Patients who had suffered from CNP for years received up to 40 neurofeedback treatment sessions, reducing their pain for several days after each session. The primary aim of this study is to apply neurofeedback therapy to a larger number of recently injured patients, who are still in a hospital. It is hypothesised that neurofeedback treatment will be more effective in people who have suffered from CNP for a shorter period of time. The secondary aim of the study is to define EEG predictors of CNP. EEG will be recorded in recently injured patients with no chronic pain, knowing that a certain number of patients will develop CNP within weeks or months. These patients will be followed up for a year and the EEGs of patients who develop CNP will be compared with those who do not.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 1, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

August 27, 2014

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2017

Completed
Last Updated

March 1, 2019

Status Verified

February 1, 2019

Enrollment Period

3.3 years

First QC Date

June 27, 2014

Last Update Submit

February 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intensity of Pain

    As measured by a numerical analogue scale

    1 year

Secondary Outcomes (4)

  • Changes in EEG activity

    1 year

  • Changes in Spasticity

    1 year

  • Changes in Mood

    1 year

  • Changes in quality of sleep

    1 year

Study Arms (3)

patients with central neuropathic pain

EXPERIMENTAL

Randomised to 20 neurofeedback therapy sessions

Other: Neurofeedback therapy

Control: patients with central neuropathic pain

OTHER

Randomised to no neurofeedback treatment

Other: No neurofeedback therapy

patients with no central neuropathic pain

NO INTERVENTION

Observed for development of central neuropathic pain

Interventions

patients with central neuropathic pain
Control: patients with central neuropathic pain

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Central Neuropathic Pain (Treatment and Control Groups)
  • Normal or corrected to normal vision
  • No history of brain disease or injury
  • Incomplete/complete spinal cord injury at level C5 to T12
  • Below level neuropathic pain for at least 6 weeks
  • Intensity of pain 4 or above (verbal numeric scale - VNS)
  • Stable medication regime responding to some extent to CNP medication treatment
  • Patients with no chronic pain
  • Normal or corrected to normal vision
  • No history of brain disease or injury
  • Incomplete/complete injury at level C5 to T12
  • Within 23 months post-injury

You may not qualify if:

  • Patients with Central Neuropathic Pain (Control and Treatment Groups)
  • Chronic or acute muscular or visceral pain larger than 4 VNS.
  • Epilepsy
  • Diagnosed mental health problems
  • Active intervention of pain team
  • Patients with no chronic pain
  • Chronic or acute pain larger than 3 on the VNS.
  • Epilepsy
  • Diagnosed mental health problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth National Spinal Injuries Unit, Southern General Hospital

Glasgow, G51 4TF, United Kingdom

Location

Related Publications (1)

  • Vuckovic A, Jajrees M, Purcell M, Berry H, Fraser M. Electroencephalographic Predictors of Neuropathic Pain in Subacute Spinal Cord Injury. J Pain. 2018 Nov;19(11):1256.e1-1256.e17. doi: 10.1016/j.jpain.2018.04.011. Epub 2018 May 8.

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Neurofeedback

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Biofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2014

First Posted

July 1, 2014

Study Start

August 27, 2014

Primary Completion

November 29, 2017

Study Completion

November 29, 2017

Last Updated

March 1, 2019

Record last verified: 2019-02

Locations